Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14

4 septembre 2018

02:00
Phagenesis Ltd, leader pionnier dans le traitement de la dysphagie, est heureuse d'annoncer aujourd'hui la publication de son dernier essai randomisé contrôlé (PHAST-TRAC) dans le journal Lancet Neurology. Reinhard Krickl, PDG de Phagenesis, a...

02:00
Phagenesis Ltd, a pioneering leader in the treatment of dysphagia, is pleased to announce today the publication of its most recent randomised controlled trial (PHAST-TRAC) in the journal Lancet Neurology. Reinhard Krickl, CEO of Phagenesis,...


3 septembre 2018

19:13
MicroPort Scientific Corporation ("MicroPort®", HK:0853) announced today that the clinical trial results for its Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") which conducted a multi-center, randomized controlled trial called...

04:00
VitalneXt BV today announces positive top-line results of a recently completed clinical study on its innovative medical nutrition (Vital01) to treat malnourished people. These were presented at the 40th Congress of 'the European Society for Clinical...


31 août 2018

18:45
An integrated analysis of one phase 2 and two phase 3 clinical trials published today in The Lancet found that the investigational medication, brexanolone injection 90 µg/kg/h (formerly SAGE-547 injection), demonstrated a reduction in depressive...

16:13
Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat high prevalence ophthalmic diseases, today announced that enrollment of patients in the company's phase 1 safety and tolerability study has...

07:30
Amneal Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced a 5-year supply and distribution agreement with American Regent for the only preservative-free generic alternative to Makena® (hydroxyprogesterone caproate injection,...

00:04
XingImaging LLC, a radiopharmaceutical production and positron emission tomography (PET) acquisition company operating in Mainland China announced today that they are using PET Imaging to support multi-center Alzheimer's disease (AD) clinical trials...


30 août 2018

09:00
Emerald Lake Safety ("ELS"), an independent group researching ways to reduce the dangerous side effects associated with prescription pharmaceuticals, will present three posters on Sept. 23-25 at the 2018 American College of Clinical Pharmacology...

09:00
Regen BioPharma Inc. and , has identified a series of small molecule drugs that inhibit NR2F6. Regen's screening process demonstrated that its recently identified novel chemical compounds appear to inhibit NR2F6 and show potential for treating...

07:00
REGENXBIO Inc. , a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced it is developing a new product candidate,...

03:30
Les résultats de l'étude de suivi de 36 mois, OPTIMIST, montrent que BlueWind Renovatm est un système minimalement invasif sûr qui génère des améliorations durables et significatives pour les patients souffrant d'hyperactivité vésicale   BlueWind...

03:30
Results from 36-month OPTIMIST Follow-Up study show BlueWind Renovatm is a safe, minimally invasive system that offers durable and significant improvements for Over Active Bladder patients  BlueWind Medical, developer of the RENOVA iStimtm, an...


29 août 2018

23:44
The American offshoot of Australian biotech Noxopharm, Nyrada, believes it is within reach of achieving a major advance in the treatment of cardiovascular disease. It has made important progress with a drug candidate known as NYX-330 that Nyrada...

18:05
COLUMBUS, Ohio, Aug. 29, 2018 /PRNewswire-PRWeb/ -- Bryan Lindsey has solidified an agreement to invest an undisclosed amount of funding in ChromoCaretm, a leading genetics-testing firm that has developed a proprietary test and multifactorial...

15:30
Ensuring that food is safe and truthfully labeled is one of our fundamental responsibilities at the U.S. Food and Drug Administration. Consumers deserve accurate information about the food they eat and how it can affect their health and nutrition....

14:16
Ardelyx, Inc. , today announced that the novel mechanism of action for tenapanor for the treatment of hyperphosphatemia, or elevated serum phosphorus, has been published in the peer-reviewed journal Science Translational Medicine. Tenapanor,...

12:00
Today the Grace Science Foundation ("GSF") announced the creation of the world's first and only NGLY1 Deficiency registry, which provides invaluable resources to the medical community racing to find a cure for this rare genetic disorder. So far, the...

09:00
Amgen today announced that the European Commission (EC) has approved an expanded indication for BLINCYTO® (blinatumomab) as monotherapy for the treatment of pediatric patients aged one year or older with Philadelphia chromosome-negative CD19...

09:00
STERO Biotechs Ltd., has received a notice of allowance and will be granted an official U.S. patent on October 2018, covering over 100 Autoimmune & chronic inflammatory diseases. The patent is for steroid sparing Cannabidiol (CBD)-based treatment...

09:00
Evofem Biosciences, Inc., ("Evofem" or the "Company"), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, believes that new...

08:57
Most people infected with Zika never show symptoms. But the virus sometimes causes severe disability ? from microcephaly in babies to weakness or partial paralysis in adults ? and there is no treatment. In a recent study in the journal Molecular &...

08:30
Trovagene, Inc. , a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs for the treatment of leukemias, lymphomas and solid tumor cancers, today announced that the European Commission (EC) has endorsed...

08:00
Sophiris Bio Inc. (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced...

08:00
Impel NeuroPharma, a Seattle-based, privately-held biopharmaceutical company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced the first subject has been dosed in a Phase 1, randomized, double-blind,...

07:30
ImaginAb, Inc., an immuno-oncology imaging company, and Centre for Probe Development and Commercialization (CPDC), a Canadian centre of excellence specializing in radiopharmaceutical development and cGMP manufacturing, today announced that they have...

07:00
Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world and a division of Bausch Health Companies Inc. , today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmitted New...

04:30
CartiHeal, le développeur du dispositif Agili-C, un implant exclusif destiné au traitement des lésions de la surface articulaire, et le Professeur Peter Verdonk, docteur en médecine, PhD, du Centre orthopédique d'Anvers à l'hôpital AZ Monica et à...

04:30
CartiHeal, developer of Agili-C, proprietary implant for the treatment of joint surface lesions, and the Principle Investigator Professor  Peter Verdonk, MD, PhD of Antwerp Orthopedic Center at AZ Monica hospital and Antwerp University, announced...

04:00
LOS ANGELES, Aug. 29, 2018 /PRNewswire-PRWeb/ -- Ovation Fertility/Life Whisperer collaborative study validates first non-invasive technology to identify specific chromosomal abnormalities using morphological assessment through artificial...

02:00
KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by...


28 août 2018

21:00
PORTLAND, Ore., Aug. 28, 2018 /PRNewswire-PRWeb/ -- Kathryn Sweas, an evidence-based energy healer, today announces the impact of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune function...

12:49
AnaBios, the leader in translational pain research, will present its clinical candidates for the treatment of chronic pain at the 17th IASP World Congress on Pain on September 12 in Boston, Mass. The molecules?part of AnaBios' advanced internal drug...

11:18
LimaCorporate est heureuse d'annoncer qu'une nouvelle étape a été franchie après l'octroi de la note ODEP (Orthopaedic Data Evaluation Panel) à l'implant SMR Reverse en mars 2018. Physica ZUK s'est vu décerner les deux notes suivantes par l'ODEP au...

10:37
High-risk patients on anticoagulants (AC) for stroke prevention also have 17% fewer deaths over 2 years of follow-up than patients who are not treated with AC   Patients who receive AC plus add-on antiplatelet therapy (AP) for stroke...

10:00
Pivotal trial results assessing the safety and efficacy of IDx-DR, an autonomous AI diagnostic system that detects diabetic retinopathy, were published online today in the peer-reviewed, open access journal Nature Digital Medicine. IDx-DR enables...

09:00
The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving...

09:00
CartiHeal, developer of Agili-C, proprietary implant for the treatment of joint surface lesions, and the Principle Investigator Professor  Peter Verdonk, MD, PhD of Antwerp Orthopedic Center at AZ Monica hospital and Antwerp University, announced...

08:25
GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) announced today the initiation of a combination trial of OXS-1550 and multi-billion dollar oncology drug, owned by a major Pharmaceutical Company (the Company). This effort is headed by Dr. Daniel...

08:00
TARIS, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, today announced positive preliminary safety and efficacy data from its clinical study of TAR-302 for the treatment of...

08:00
Oakton Primary Care Center is pleased to announce they now offer GAINSWave! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction (ED) symptoms. As men age,...

07:02
LimaCorporate is proud to announce that another milestone has been reached following the SMR Reverse ODEP Ratings in March 2018. Physica ZUK has been awarded by the Orthopaedic Data Evaluation Panel (ODEP) in the UK with the following two ratings...

07:00
Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing therapies for urologic conditions, today announced it has licensed a novel investigational gene therapy for patients with overactive bladder (OAB) symptoms who have...

06:00
A new study that was recently published in the International Journal of Chronic Obstructive Pulmonary Disease, led by Riccardo Polosa, MD, PhD (Department of Clinical and Experimental Medicine of the University of Catania, Italy), suggests that...

06:00
Une nouvelle étude récemment publiée dans l'International Journal of Chronic Obstructive Pulmonary Disease, réalisée par le Dr. Riccardo Polosa, PhD (Département de médecine clinique et expérimentale de l'Université de Catania, en Italie), suggère...

03:00
The Global ETNA-AF programme is a large and comprehensive single non-vitamin K oral anticoagulant (NOAC) repository of real-world data, as part of the Edoxaban Clinical Research Programme, EDOSURE Three snapshot analyses from baseline data add to...

02:23
On May 25, the world's authoritative academic journal Nature Communications published The Genomic Landscape of TERT Promoter Wildtype-IDH Wildtype Glioblastoma, an online paper about the latest study achievements on glioblastoma. The study was led by...

00:01
Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, exhibits data highlighting comparable safety and efficacy of its INNOVO® therapy, an externally worn...


27 août 2018

21:00
Results shared at the American Diabetes Association's (ADA) 78th Scientific Sessions Wellthy Therapeutics , a leading digital health company in chronic disease management through its digital therapeutics platform Wellthy Care, recently announced...

12:00
Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced one-year follow-up data from the REDUCE LAP-HF I clinical study of its Interatrial Shunt Device (IASD®). The IASD is...

1 2 3 4 5 6 7 8 9 10 11 12 13 14